<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34729276</PMID><DateRevised><Year>2021</Year><Month>11</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Management of Long-COVID Postural Orthostatic Tachycardia Syndrome With Enhanced External Counterpulsation.</ArticleTitle><Pagination><StartPage>e18398</StartPage><MedlinePgn>e18398</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e18398</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.18398</ELocationID><Abstract><AbstractText>A growing number of patients diagnosed with COVID-19 disease have been reported to have postural orthostatic tachycardia syndrome (POTS) after the acute phase. A 57-year-old female was diagnosed with COVID-19 in December 2020. As a result of her acute illness, she was hospitalized for COVID pneumonia and respiratory failure, followed&#xa0;by stays at an acute care facility and home rehabilitation center. After the acute phase, the patient was diagnosed with long-COVID-19-associated&#xa0;POTS with symptoms such as fatigue, "brain fog," and dyspnea. The patient was referred to an enhanced external counterpulsation (EECP) treatment center and underwent 15, one-hour sessions over three weeks. Upon completion of therapy, the patient reported improvements with&#xa0;"brain fog" and the ability to perform activities of daily living. Her Patient-Reported Outcome Measurement Information System (PROMIS) Fatigue score was reduced by three points, six-minute walk distance increased by 85 feet, and Duke Activity Status Index (DASI) improved by over 15 points. EECP therapy was chosen due to the overlap in&#xa0;underlying pathology driving POTS and the mechanisms of action of EECP. This report is the first case of using EECP for the successful management of COVID-19-associated POTS and warrants further trials.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021, Varanasi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Varanasi</LastName><ForeName>Swathi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Medical Affairs, Flow Therapy, Fort Worth, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sathyamoorthy</LastName><ForeName>Mohankrishnan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, University of North Texas Health Science Center, Fort Worth, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chamakura</LastName><ForeName>Sanjayanth</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiology, Medical City North Hills, North Richland Hills, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shah</LastName><ForeName>Sachin A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Pharmacy, University of the Pacific, Stockton, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">covid long haul syndrome</Keyword><Keyword MajorTopicYN="N">eecp</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">pasc</Keyword><Keyword MajorTopicYN="N">postural orthostatic tachycardia syndrome</Keyword></KeywordList><CoiStatement>The authors have declared financial relationships, which are detailed in the next section.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34729276</ArticleId><ArticleId IdType="pmc">PMC8555928</ArticleId><ArticleId IdType="doi">10.7759/cureus.18398</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Confronting our next national health disaster - long-haul Covid. Phillips S, Williams MA. N Engl J Med. 2021;385:577&#x2013;579.</Citation><ArticleIdList><ArticleId IdType="pubmed">34192429</ArticleId></ArticleIdList></Reference><Reference><Citation>More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. Johansson M, St&#xe5;hlberg M, Runold M, et al. JACC Case Rep. 2021;3:573&#x2013;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Blitshteyn S, Whitelaw S. Immunol Res. 2021;69:205&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8009458</ArticleId><ArticleId IdType="pubmed">33786700</ArticleId></ArticleIdList></Reference><Reference><Citation>6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Huang C, Huang L, Wang Y, et al. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Ruzieh M, Batizy L, Dasa O, Oostra C, Grubb B. Scand Cardiovasc J. 2017;51:243&#x2013;247.</Citation><ArticleIdList><ArticleId IdType="pubmed">28738696</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced external counterpulsation as a novel treatment for post-acute COVID-19 sequelae. Dayrit JK, Verduzco-Gutierrez M, Teal A, Shah SA. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8110286</ArticleId><ArticleId IdType="pubmed">33987042</ArticleId></ArticleIdList></Reference><Reference><Citation>Autoimmune postural orthostatic tachycardia syndrome. Watari M, Nakane S, Mukaino A, et al. Ann Clin Transl Neurol. 2018;5:486&#x2013;492.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899914</ArticleId><ArticleId IdType="pubmed">29687025</ArticleId></ArticleIdList></Reference><Reference><Citation>Impaired endothelial function in patients with postural tachycardia syndrome. Chopoorian AH, Wahba A, Celedonio J, et al. Hypertension. 2021;77:1001&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7878337</ArticleId><ArticleId IdType="pubmed">33486983</ArticleId></ArticleIdList></Reference><Reference><Citation>Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Braith RW, Conti CR, Nichols WW, Choi CY, Khuddus MA, Beck DT, Casey DP. Circulation. 2010;122:1612&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2963100</ArticleId><ArticleId IdType="pubmed">20921442</ArticleId></ArticleIdList></Reference><Reference><Citation>Postural orthostatic tachycardia&#xa0;syndrome: JACC Focus Seminar. Bryarly M, Phillips LT, Fu Q, Vernino S, Levine BD. J Am Coll Cardiol. 2019;73:1207&#x2013;1228.</Citation><ArticleIdList><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>